Former vice president of infectious disease research at Wyeth and ACSH advisor Dr. David Shlaes knows a thing or two about dealing with the FDA, and its misguided policies regarding approval of new antibiotics.
Plan B becoming available to girls of all ages was a huge victory for contraception availability advocates. However, lifting the age restrictions for Teva s Plan B One-Step
The FDA s Center for Tobacco Products, through its head, Mitch Zeller, made yet another non-announcement yesterday concerning menthol cigarettes. The 2009 law
The FDA is at it again, this time with a proposal on acceptable levels of arsenic
It is estimated that over 20 million American women suffer from moderate-to-severe peri-menopausal hot flashes, and that most of its sufferers are not treating them. Some of that non-treatment stems from the federal WHI study of 2002 which seemed to show several serious risks from the most effective form of menopausal symptom treatment, hormone replacement therapy (HRT).
LOST IN ALL OF THE HULLABALOO surrounding the FDA s reversal last week of its 1962 ban on Thalidomide, the drug that was linked to horrific birth defects, was perhaps an even greater story: what essentially amounts to the very refocussing of the FDA s raison d etre. When the FDA reversed itself and approved Thalidomide, there was no suggestion that the teratogenic results of Thalidomide would no longer occur. Rather, the move signals a changing of the paradigm that guides the agency.
New York, June 15, 1998 The American Council on Science and Health (ACSH), a public health, consumer advocacy organization, will be holding a news conference to expose the deceptive practices of the food police group, Center for Science in the Public Interest. ACSH will release information obtained while monitoring CSPI's propaganda campaign against the fat free oil, Olestra. CSPI's vendetta to have the FDA approved additive removed as a choice consumers now enjoy in their diet has led the food police group to knowingly engage in deceptive practices.
The American Council on Science and Health (ACSH) today called on the Food and Drug Administration to approve irradiation of beef to limit Americans' exposure to E. coli bacteria
A self-styled consumer group is deliberately distorting the facts to scare the public about a perfectly safe sweetener, the American Council on Science and Health announced today. ACSH, a consortium of more than 200 scientists, was responding to unfounded charges by the Center for Science in the Public Interest that the no-calorie sweetener Acesulfame-K causes cancer. Ace-K is currently used in sugar-free gum, instant puddings, gelatin desserts, and thousands of other foods. Its manufacturer, Hoechst, recently asked the FDA for permission to expand the sweetener's use to diet soft drinks. Ace-K is already used to sweeten soft drinks in Canada and Europe.
The latest news from Washington is both tasty and satisfying: Food and Drug Administration Commissioner David Kessler has agreed with his scientific advisory panel and approved Olestra, the first noncaloric fat replacer, for limited use. Within months we will be able to buy a variety of delectable zero-fat snacks a real-life case of getting something for (almost) nothing. Dr. Kessler's decision represents a triumph of sound science and common sense over scaremongering with the American consumer the clear winner. Despite the shrill objections of public health nannies the FDA has rejected the sort of government paternalism that argues, "we know what's best for you; and since you might misuse this new product, we are going to withhold it to protect you from yourself."